Cipla Limited — Paracetamol Exporter Profile
Indian Pharmaceutical Exporter · #12 for Paracetamol · $6.2M export value · DGFT Verified
Cipla Limited is the #12 Indian exporter of Paracetamol with $6.2M in export value and 634 verified shipments. Cipla Limited holds a 1.7% market share in Paracetamol exports across 13 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Paracetamol Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Paracetamol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $4.5M | 401 | 31.1% |
| UNITED KINGDOM | $2.5M | 517 | 17.2% |
| NEW ZEALAND | $2.3M | 107 | 16.0% |
| KENYA | $1.7M | 82 | 11.5% |
| TURKEY | $1.2M | 132 | 8.1% |
| YEMEN, DEMOCRATIC | $590.2K | 53 | 4.1% |
| IRAQ | $479.4K | 39 | 3.3% |
| BELGIUM | $404.7K | 69 | 2.8% |
| MADAGASCAR | $344.2K | 35 | 2.4% |
| TRINIDAD & TOBAGO | $161.0K | 17 | 1.1% |
Cipla Limited exports Paracetamol to 17 countries. The largest destination is AUSTRALIA accounting for 31.1% of Cipla Limited's Paracetamol shipments, followed by UNITED KINGDOM (17.2%) and NEW ZEALAND (16.0%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Paracetamol from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALLOGA UK LTD | UNITED KINGDOM | $2.4M | 483 |
| HELLMANN WORLDWIDE LOGISTICS | NEW ZEALAND | $1.6M | 55 |
| NOUMED PHARMACEUTICALS PTY LTD | AUSTRALIA | $1.4M | 165 |
| CIPLA KENYA LTD C/O IMPERIAL | KENYA | $1.0M | 49 |
| ALKIMMA SCIENTIFIC BUREAU | IRAQ | $740.2K | 74 |
| CIPLAMEDICA PHARMACEUTICAL INDUSTRI | YEMEN, DEMOCRATIC | $608.1K | 64 |
| APOTEX AUSTRALIA | AUSTRALIA | $554.3K | 31 |
| ROZ LOGISTICS | TURKEY | $475.2K | 52 |
| JAMES CRISP LTD, | NEW ZEALAND | $466.2K | 29 |
| HIGEN COMPANY | TURKEY | $436.9K | 45 |
Cipla Limited supplies Paracetamol to 59 buyers globally. The largest buyer is ALLOGA UK LTD (UNITED KINGDOM), followed by HELLMANN WORLDWIDE LOGISTICS (NEW ZEALAND) and NOUMED PHARMACEUTICALS PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Paracetamol Export Value and How Much Does Cipla Limited Contribute?
India exported $157.4M worth of Paracetamol through 15,000 shipments from 870 suppliers to 170 countries, serving 2,197 buyers globally. Cipla Limited contributes $6.2M to this total, accounting for 1.7% of India's Paracetamol exports. Cipla Limited ships Paracetamol to 17 countries through 59 buyers.
What Is the Average Shipment Value for Cipla Limited's Paracetamol Exports?
Cipla Limited's average Paracetamol shipment value is $9.8K per consignment, based on 634 shipments totaling $6.2M. The largest destination is AUSTRALIA (31.1% of Cipla Limited's Paracetamol exports).
How Does Cipla Limited Compare to Other Indian Paracetamol Exporters?
Cipla Limited ranks #12 among 870 Indian Paracetamol exporters with a 1.7% market share. The top 3 exporters are ADCOCK INGRAM LIMITED ($27.7M), IPCA LABORATORIES LIMITED ($23.3M), INDOCO REMEDIES LIMITED ($21.6M). Cipla Limited processed 634 shipments to 13 destination countries.
What Paracetamol Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ETHICS PARACETAMOL 120 MG /5 ML ORAL SUS | $726.0K | 21 |
| PARACIP IV (PARACETAMOL INJECTION 1000MG/100ML) | $671.1K | 48 |
| CIPLADON 1000MG TABLET (PARACETAMOL 1000 | $373.4K | 19 |
| PARACETAMOL SANDOZ PHARMA TABLET 500 MG | $315.9K | 13 |
| PRICELINE PARACETAMOL 500 MG (PARACETAMO | $310.1K | 36 |
| ETHICS PARACETAMOL 120 MG 5 ML ORAL SUSPENSION PARACETAMOL 120 MG 5 ML ORAL SUSPENSION | $250.9K | 8 |
| PARACIP IV (PARACETAMOL INJECTION 1000MG/100ML) (1X100 ML) | $245.0K | 30 |
| WAGNER PARACETAMOL 500 MG TABLET ( PARAC | $189.5K | 10 |
| ETHICS PARACETAMOL 120MG/5ML ORAL SUSPENSION (PARACETAMOL 120MG/5ML ORAL SUSPENSION) | $165.8K | 10 |
| PARACODINE TABLET (PARACETAMOL 500MG + C | $161.0K | 17 |
Cipla Limited exports 579 distinct Paracetamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ETHICS PARACETAMOL 120 MG /5 ML ORAL SUS with 21 shipments worth $726.0K.
Regulatory Requirements: Exporting Paracetamol to Key Markets
What Cipla Limited must comply with to export Paracetamol to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Paracetamol Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | SOCOMED PHARMA PRIVATE LIMITED | $6.9M | 244 | 13 | $28.2K |
| 10 | MARKSANS PHARMA LIMITED | $6.3M | 293 | 7 | $21.6K |
| 12 | CIPLA LIMITED ★ | $6.2M | 634 | 13 | $9.8K |
| 13 | MEDOPHARM | $6.1M | 180 | 24 | $33.7K |
| 14 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $5.3M | 308 | 5 | $17.2K |
Cipla Limited ranks #12 among 870 Indian Paracetamol exporters. Average shipment value of $9.8K compared to the market average of $180.9K. The closest competitors by value are SOCOMED PHARMA PRIVATE LIMITED and MARKSANS PHARMA LIMITED.
Which Indian Ports Ship Paracetamol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 4,107 | 27.4% |
| BANGALORE ICD (INWFD6) | 1,125 | 7.5% |
| JNPT | 959 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 763 | 5.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 717 | 4.8% |
| AHEMDABAD ICD (INSBI6) | 620 | 4.1% |
| MUNDRA SEA (INMUN1) | 480 | 3.2% |
| CHENNAI SEA (INMAA1) | 410 | 2.7% |
Geopolitical & Trade Policy Impact on Cipla Limited's Paracetamol Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Paracetamol, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paracetamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paracetamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,506 individual customs records matching Cipla Limited exporting Paracetamol, covering 579 formulations to 17 countries via 59 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paracetamol Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Paracetamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Paracetamol Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paracetamol. For current shipment-level data, contact TransData Nexus.